Ceritinib D7 is a deuterium-labeled active pharmaceutical ingredient used in research and pharmaceutical manufacturing. It is a chemical compound with a complex structure containing amine, ether, and halogen functional groups, designed for analytical and developmental studies.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1632484-77-5
Sitafloxacin hydrate (2:3)
pharmaceutical raw material
((plusmn))-Zanubrutinib
pharmaceutical raw material
(4S)-1-(4-Fluorophenyl)-3-[(3R)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one
pharmaceutical raw material
Teriflunomide
pharmaceutical raw material
Ceritinib
pharmaceutical raw material
5-chloro-2-N-[2-(1,1,1,2,3,3,3-heptadeuteriopropan-2-yloxy)-5-methyl-4-piperidin-4-ylphenyl]-4-N-(2-propan-2-ylsulfonylphenyl)pyrimidine-2,4-diamine
VERWOWGGCGHDQE-WFBMWZOZSA-N
[2H]C([2H])([2H])C([2H])(C([2H])([2H])[2H])OC1=C(C=C(C(=C1)C2CCNCC2)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl